Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells

Molecular Carcinogenesis

Volumn 47, Issue 7, 2008, Pages 485-491

  Yang, Sun ^a,b   Misner, Bobbye ^a   Chiu, Rita ^a   Meyskens Jr , Frank L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; H2O2; JB6P cells; Metal; UVB

Indexed keywords

CADMIUM CHLORIDE; CARCINOGEN; HYDROGEN PEROXIDE; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; FOSL2 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZING AGENT; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR FRA 2;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION; WESTERN BLOTTING; ANIMAL; CELL ADHESION; DIMERIZATION; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; PROMOTER REGION; RADIATION EXPOSURE; TRANSACTIVATION; ULTRAVIOLET RADIATION;

ANIMALS; BLOTTING, WESTERN; CADMIUM CHLORIDE; CARCINOGENS; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; DIMERIZATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FOS-RELATED ANTIGEN-2; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; REACTIVE OXYGEN SPECIES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

EID: 45949089919     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20410     Document Type: Article

References (51)

1. Dong Z, Cmarik JL, Wendel EJ, Colburn NH. Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 1994;15:1001-1004.
2. Colburn N, Wendel E, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters mitogen-resistance variants are sensitive to promotion. Proc Natl Acad Sci USA 1981;78:6912-6916.
3. Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989;244:566-569.
4. Meyskens FL Jr, McNulty SE, Buckmeier JA, et al. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 2001;31:799-808.
5. Singh N, Aggarwal S. The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells. Int J Cancer 1995; 62:107-114.
6. Muehlematter D, Larsson R, Cerutti P. Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis 1988;9:239-245.
7. Murakami A, Kawabata K, Koshiba T, et al. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: The role of tumor necrosis factor-alpha. Cancer Res 2000; 60:6326-6331.
8. Huang RP, Fan Y, Boynton AL. UV irradiation upregulates Egr-1 expression at transcription level. J Cell Biochem 1999;73:227-236.
9. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
10. 2 in Saccharomyces cerevisiae. J Biol Chem 2004;279: 6501-6506.
11. Kim H, Kim YN, Kim H, Kim CW. Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction. Oncogene 2005;24:1252-1261.
12. Shigemura K, Sung SY, Kubo H, et al. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate 2007;67:722-731.
13. Bertin G, Averbeck D. Cadmium: Cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie 2006;88: 1549-1559.
14. Badisa V, Latinwo L, Odewumi C, et al. Mechanism of DNA damage by cadmium and interplay of antioxidant enzymes and agents. Environ Toxicol 2006;10:144-151.
15. Souza V, Escobar Md Mdel C, Gómez-Quiroz Luis, et al. Acute cadmium exposure enhances AP-1 DNA binding and induces cytokines expression and heat shock protein 70 in HepG2 cells. Toxicology 2004;197:213-228.
16. Hsiao CJ, Stapleton SR. Characterization of Cd-induced molecular events prior to cellular damage in primary rat hepatocytes in culture: Activation of the stress activated signal protein JNK and transcription factor AP-1. J Biochem Mol Toxicol 2004;18:133-142.
17. Yang S, McNulty S, Meyskens FL Jr. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res 2004;17:74-83.
18. Dhar A, Young MR, Colburn NH. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Mol Cell Biochem 2002;234-235:185-193.
19. Yang S, Misner B, Chiu R, Meyskens FL. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis 2007;28:2382-2390.
20. Hsu TC, Young MR, Cmarik J, Colburn NH. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000;28:1338-1348.
21. Eferl R, Wagner EF. AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-868.
22. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci 2004;117:5965-5973.
23. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005;41:2449-2461.
24. Belguise K, Kersual N, Galtier F, Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005;24:1434-1444.
25. Young MR, Colburn NH. Fra-1 a target for cancer prevention or intervention. Gene 2006;379:1-11.
26. Liu YC, Hsiao HH, Chang JG, et al. Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy. Int J Hematol 2006;84:425-431.
27. Somervaille TC, Geary ML. PU.1 and Junb: Suppressing the formation of acute myeloid leukemia stem cells. Cancer Cell 2006;10:456-457.
28. Mao X, Orchard G, Lillington DM, et al. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Neoplasia 2003;101:1513-1519.
29. Rassidakis GZ, Thomaides A, Atwell C, et al. JunB expression is a common feature of CD30+ lymphomsd and lymp. Mod Pathol 2005;18:1365-1370.
30. Bamberger AM, Milde-Langosch K, Rossing E, Goemann C, Loning T. Expression pattern of the AP-1 family in endometrial cancer: Correlations with cell cycle regulators. J Cancer Res Clin Oncol 2001;127:545-550.
31. Foletta VC. Transcription factor AP-1, and the role of Fra-2. Immunol Cell Biol 1996;74:121-133.
32. Eferl R, Zenz R, Theussl HC, Wagner EF. Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis 2007;45:447-451.
33. Milde-Langosch K, Janke S, Wagner I, et al. Role of Fra-2 in breast cancer: Influence on tumor cell invasion and motility. Breast Cancer Res Treat 2007; [Epub ahead of print].
34. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 2002;22:4952-4964.
35. Yang S, Meyskens FL Jr. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol Pharmacol 2005;67:298-308.
36. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005;41:2449-2461.
37. Isoherranen K, Westermarck J, Kahari VM, Jansen C, Punnonen K. Differential regulation of the AP-1 family members by UV irradiation in vitro and in vivo. Cell Signal 1998;10:191-195.
38. Kristoffer V, Yacoub A, Hagan M, et al. Radiation-induced cell signaling: Inside-out and outside-in. Mol Cancer Ther 2007;6:789-801.
39. Nomura M, Ma WY, Huang C, et al. Inhibition of ultraviolet B-induced AP-1 activation by Theaflavins from black tea. Mol Carcinog 2000;28:148-155.
40. Reddy K, Nabha S, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003;22:395-403.
41. Leal RB, Posser T, Rigon AP, et al. Cadmium stimulates MAPKs and Hsp27 phosphorylation in bovine adrenal chromaffin cells. Toxicology 2007;234:34-43.
42. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 2006;25:695-705.
43. Chen W, Tang Q, Gonzales MS, Bowden GT. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 2001;20:3921-3926.
44. Rezvani HR, Dedieu S, North S, et al. Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem 2007;282:16413-16422.
45. Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 2007;27:3936-3950.
46. Vial E, Marshall CJ. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 2003;116:4957-4963.
47. Gruda MC, Kovary K, Metz R, Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 1994;9:2537-2547.
48. Young MR, Nair R, Bucheimer N, et al. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol 2002;22: 587-598.
49. Singh RP, Dhanalakshmi S, Mohan S, Agarwal C, Agarwal R. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells. Mol Cancer Ther 2006;5:1145-1153.
50. 2: Relevance in inflammation and synergy with TNF-alpha. J Immunol 2007;178:3893-3902.
51. Singh N, Khanna N, Sharma H, Kundu S, Azmi S. Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-derived RT-101 cells. Biochem Biophys Res Commun 2002;295:24-30.